Skip to main content

. 1974 May;120(5):392–399.

The problem of diagnosis and classification of chronic hepatitis.

PMCID: PMC1130144 PMID: 4839484

392

Images in this article

Chart 3.
on p.395

Chart 4.
on p.396

Figure 1.
on p.397

Figure 2.
on p.397

Figure 3.
on p.398

Figure 4.
on p.398

Figure 5.
on p.398

Figure 6.
on p.398

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Baggenstoss A. H., Soloway R. D., Summerskill W. H., Elveback L. R., Schoenfield L. J. Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution. Hum Pathol. 1972 Jun;3(2):183–198. doi: 10.1016/s0046-8177(72)80072-8. [DOI] [PubMed] [Google Scholar]
Becker M. D., Baptista A., Scheuer P. J., Sherlock S. Prognosis of chronic persistent hepatitis. Lancet. 1970 Jan 10;1(7637):53–57. doi: 10.1016/s0140-6736(70)91843-x. [DOI] [PubMed] [Google Scholar]
Boyer J. L., Klatskin G. Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). N Engl J Med. 1970 Nov 12;283(20):1063–1071. doi: 10.1056/NEJM197011122832001. [DOI] [PubMed] [Google Scholar]
Krugman S., Giles J. P., Hammond J. Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA. 1967 May 1;200(5):365–373. doi: 10.1001/jama.200.5.365. [DOI] [PubMed] [Google Scholar]
Mistilis S. P., Blackburn C. R. Active chronic hepatitis. Am J Med. 1970 Apr;48(4):484–495. doi: 10.1016/0002-9343(70)90049-5. [DOI] [PubMed] [Google Scholar]
Nielsen J. O., Dietrichson O., Elling P., Christoffersen P. Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Engl J Med. 1971 Nov 18;285(21):1157–1160. doi: 10.1056/NEJM197111182852101. [DOI] [PubMed] [Google Scholar]
Shulman N. R. Hepatitis-associated antigen. Am J Med. 1970 Nov;49:669–692. doi: 10.1016/S0002-9343(70)80133-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
Soloway R. D., Summerskill W. H., Baggenstoss A. H., Geall M. G., Gitnićk G. L., Elveback I. R., Schoenfield L. J. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972 Nov;63(5):820–833. [PubMed] [Google Scholar]
Sutnick A. I., Oski F. A., London W. T., Millman I., Blumberg B. S. Erythrocyte glucose-6 phosphate dehydrogenase (G6PD) and Australia antigen hepatitis in Down's syndrome. Res Commun Chem Pathol Pharmacol. 1970 Jan;1(1):3–8. [PubMed] [Google Scholar]

ACTIONS

PDF (1.9 MB)

RESOURCES